Related Experiment Videos

DNA ploidy and S-phase fraction as prognostic factors in cervical cancer

M L Rothenberg¹

¹University of Texas Health Science Center, Dept. of Medicine, San Antonio, Texas 78284-7884.

Cancer Treatment and Research

|January 1, 1994

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023

The role of nonrandomized trials in the evaluation of oncology drugs.

Clinical pharmacology and therapeutics·2015

Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031.

Annals of oncology : official journal of the European Society for Medical Oncology·2010

Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies.

Annals of oncology : official journal of the European Society for Medical Oncology·2009

Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study.

Annals of oncology : official journal of the European Society for Medical Oncology·2008

Phase I trial of oral MAC-321 in subjects with advanced malignant solid tumors.

Cancer chemotherapy and pharmacology·2006

See all related articles